PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 111 filers reported holding PLIANT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,227 | -4.3% | 532,079 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $9,641 | -31.7% | 532,079 | +0.2% | 0.02% | -41.2% |
| Q1 2023 | $14,121 | +31.7% | 530,896 | -4.3% | 0.03% | +30.8% |
| Q4 2022 | $10,726 | -99.9% | 554,891 | -5.8% | 0.03% | -18.8% |
| Q3 2022 | $12,310,000 | +186.0% | 589,266 | +9.7% | 0.03% | +190.9% |
| Q2 2022 | $4,304,000 | +14.3% | 537,379 | 0.0% | 0.01% | +37.5% |
| Q1 2022 | $3,767,000 | -48.1% | 537,379 | 0.0% | 0.01% | -46.7% |
| Q4 2021 | $7,255,000 | -20.0% | 537,379 | 0.0% | 0.02% | -21.1% |
| Q3 2021 | $9,071,000 | -42.0% | 537,379 | 0.0% | 0.02% | -44.1% |
| Q2 2021 | $15,648,000 | -26.0% | 537,379 | 0.0% | 0.03% | -33.3% |
| Q1 2021 | $21,135,000 | +73.1% | 537,379 | 0.0% | 0.05% | +59.4% |
| Q4 2020 | $12,209,000 | +0.3% | 537,379 | 0.0% | 0.03% | -11.1% |
| Q3 2020 | $12,172,000 | -30.2% | 537,379 | 0.0% | 0.04% | -34.5% |
| Q2 2020 | $17,443,000 | – | 537,379 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |